
About Jeevan Scientific Technology
Jeevan Scientific Technology is a publicly listed company based in Hyderabad (India) founded in 1999. Healthcare outsourcing services are provided by Jeevan Scientific Technology. The company has 263 employees. Its chief executive, as recorded, is Rajendra Prasad Muppavarapu. Its Indian entity Jeevan Scientific Technology Limited reported revenue of ₹62.51 Cr. Jeevan Scientific Technology offers products and services including BA/BE Studies, Clinical Trial Services, and Pharmacovigilance Services. Its focus areas include BPO Services, Industry Specific and Healthcare.
Company details
Jeevan Scientific Technology was founded in 1999 and is headquartered in Hyderabad, India. Outsourcing services in the healthcare sector are delivered, including support for clinical and operational needs. The company operates from its Indian base, serving clients in pharmaceuticals and related fields. Leadership is held by CEO Rajendra Prasad Muppavarapu, with a focus on established processes in the domain.
- Headquarters Hyderabad, India
- Employees 263
- Stage Public
- SectorsBusiness Services
- Email••••••••
- Website jeevanscientific.com
- Social LinkedIn X Facebook
- Legal Name Jeevan Scientific Technology Ltd
- Market Cap₹173 Cr
JSTL · BSE
- Share Price₹87.00
+1.16% today
- Revenue₹61.54 Cr
FY 2025-26 · +31.4% YoY
- EBITDA₹9.80 Cr
Margin 15.9%
- Net Profit₹1.15 Cr
FY 2025-26 · +618.8% YoY
- P/E (TTM)25.3x
P/B 2.4x
- Employee Count263
Associated legal entities of Jeevan Scientific Technology
Jeevan Scientific Technology is associated with 2 registered companies on The Company Check; the primary company is Jeevan Scientific Technology Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Jeevan Scientific Technology Limited Listed CIN L72200TG1999PLC031016 | Active | 02 Feb 1999 | Hyderabad, Telangana | ₹62.5 Cr | 250 | 11 | View details |
| Jstl Pharma Llp CIN AAT-2878 | Active | 10 Aug 2020 | Hyderabad, Telangana | 2 | View details |
Products & Services of Jeevan Scientific Technology
Jeevan Scientific Technology offers a comprehensive portfolio of products and services, including BA/BE Studies, Clinical Trial Services, and Pharmacovigilance Services.
Conducts bioequivalence studies for various therapeutic areas.
Manages trials from Phase II to IV for drugs and devices.
Provides monitoring and reporting for drug safety compliance.
Board of directors of Jeevan Scientific Technology Limited (Jeevan Scientific Technology)
Jeevan Scientific Technology Limited is the primary company behind Jeevan Scientific Technology. The boards of the 2 registered companies of Jeevan Scientific Technology currently have 9 directors; the longest-serving is Krishna Kishore Kuchipudi, appointed in 2020. 26 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Krishna Kishore Kuchipudi DIN 00876539 | Designated Partner | 10 Aug 2020 | 6 yrs 3 mo | Jstl Pharma Llp, Jeevan Scientific Technology Limited |
| Kuchipudi Vanaja DIN 01030437 | Designated Partner | 10 Aug 2020 | 6 yrs 3 mo | Jstl Pharma Llp |
| Jeevan Krishna Kuchipudi DIN 08207809 | Director | 02 Nov 2020 | 6 yrs | Jeevan Scientific Technology Limited |
| Snigdha Mothukuri DIN 08934860 | Whole-time director | 02 Nov 2020 | 6 yrs | Jeevan Scientific Technology Limited |
| Nageswar Rao Yarllagadda DIN 00293474 | Whole-time director | 23 Jun 2021 | 5 yrs 4 mo | Jeevan Scientific Technology Limited |
| Venkata Subba Rao Guttikonda DIN 01900749 | Director | 25 Mar 2022 | 4 yrs 7 mo | Jeevan Scientific Technology Limited |
| Suryaprakasa Rao Bommisetti DIN 08089189 | Director | 25 Mar 2022 | 4 yrs 7 mo | Jeevan Scientific Technology Limited |
| Divakar Atluri DIN 00033386 | Director | 14 Aug 2023 | 3 yrs 3 mo | Jeevan Scientific Technology Limited |
| Gollapinwi Mallikarjuna DIN 11189083 | Director | 14 Aug 2025 | 1 yr 3 mo | Jeevan Scientific Technology Limited |
People of Jeevan Scientific Technology
1 people are tracked at Jeevan Scientific Technology (1 in leadership); the tracked headcount is 263.
| Name | Role | Group |
|---|---|---|
Rajendra Prasad Muppavarapu | CEO | Leadership |
Complete people profiles for Jeevan Scientific Technology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Jeevan Scientific Technology
Jeevan Scientific Technology is a publicly listed company on the BSE with ticker symbol JSTL in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date19 Dec 2014
- Listed onBSE: 538837
- Listed entityJeevan Scientific Technology Ltd
- Exchange sectorHealth services
- ISININE237B01018
- Share price₹87.36 (+4.11% on the day) · 2026-10-14
- Market capitalisation₹168 Cr
- Price to earnings42.9
- EPS (diluted, trailing year)₹2.03
- Volume (last session)50,025
Financials of Jeevan Scientific Technology
Exchange-reported figures of Jeevan Scientific Technology Limited, the listed company behind Jeevan Scientific Technology (BSE: JSTL).
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 61.54 | 46.84 | 39.65 | 36.18 | 67.79 | 46.95 | 23.94 |
| Revenue growth | +31.4% | +18.1% | +9.6% | -46.6% | +44.4% | +96.1% | - |
| EBITDA | 9.80 | 7.48 | 4.63 | 1.35 | 16.75 | 17.48 | (6.12) |
| EBITDA margin | +15.9% | +16.0% | +11.7% | +3.7% | +24.7% | +37.2% | -25.6% |
| Profit before tax | 2.09 | 0.06 | (1.61) | (3.69) | 18.02 | 13.64 | (10.55) |
| Net profit | 1.15 | 0.16 | (1.30) | (3.06) | 9.26 | 11.73 | (8.56) |
| Net profit margin | +1.9% | +0.3% | -3.3% | -8.5% | +13.7% | +25.0% | -35.8% |
| EPS (₹) | 0.61 | 0.08 | (0.84) | (1.97) | 7.81 | 7.67 | (5.61) |
| Balance sheet | |||||||
| Total assets | - | 71.21 | 62.45 | 58.83 | 63.40 | 45.69 | 41.43 |
| Net worth | - | 49.94 | 48.43 | 48.19 | 50.58 | 35.02 | 23.22 |
| Total debt | - | 20.58 | 13.41 | 10.10 | 12.55 | 10.34 | 17.95 |
| Cash & bank | - | 0.24 | 0.54 | 6.83 | 29.71 | 6.21 | 2.20 |
| Net working capital | - | 21.67 | 19.26 | 22.09 | 39.91 | 13.59 | 5.63 |
| Cash flow | |||||||
| Cash from operations | - | 10.07 | 2.89 | (6.41) | 19.56 | 4.95 | (0.01) |
| Cash from investing | - | (15.62) | (11.53) | (6.93) | (1.20) | (0.80) | (1.90) |
| Cash from financing | - | 5.24 | 2.35 | (9.54) | 5.67 | (0.13) | 0.44 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 23.17 | 18.28 | 21.29 | 19.07 | 12.38 | 8.80 | 10.06 | 12.51 |
| Revenue growth (YoY) | +87.2% | +107.7% | +111.6% | +52.4% | +8.6% | -31.7% | - | - |
| Other income | 0.44 | 0.17 | 0.29 | 0.14 | 0.20 | 0.33 | 0.15 | 0.23 |
| EBITDA | 5.71 | 2.95 | 4.29 | 5.23 | 2.07 | (1.78) | (0.38) | 2.08 |
| EBITDA margin | +24.6% | +16.1% | +20.2% | +27.4% | +16.7% | -20.2% | -3.8% | +16.6% |
| Depreciation | 1.80 | 1.70 | 1.61 | 1.60 | 1.69 | 1.74 | 1.77 | 1.48 |
| Interest | 0.48 | 0.44 | 0.41 | 0.54 | 0.55 | 0.54 | 0.55 | 0.43 |
| Profit before tax | 3.87 | 0.98 | 2.56 | 3.23 | 0.03 | (3.73) | (2.55) | 0.40 |
| Tax | 0.97 | 0.11 | 0.73 | 0.83 | 0.02 | (0.51) | (1.29) | 0.35 |
| Net profit | 2.90 | 0.87 | 1.83 | 2.40 | 0.01 | (3.22) | (1.26) | 0.05 |
| EPS (₹) | 1.44 | 0.43 | 1.09 | 1.52 | 0.01 | (2.03) | (0.79) | 0.03 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 53.93 | 43.61 | 38.50 | 36.18 | 56.55 | 40.47 | 20.57 |
| Revenue growth | +23.7% | +13.3% | +6.4% | -36.0% | +39.7% | +96.7% | - |
| EBITDA | 8.48 | 6.53 | 4.38 | 1.35 | 17.06 | 16.63 | (5.82) |
| EBITDA margin | +15.7% | +15.0% | +11.4% | +3.7% | +30.2% | +41.1% | -28.3% |
| Profit before tax | 2.64 | 0.77 | (1.23) | (3.62) | 18.33 | 13.17 | (9.78) |
| Net profit | 1.65 | 0.73 | (1.05) | (3.01) | 9.54 | 11.25 | (7.79) |
| Net profit margin | +3.1% | +1.7% | -2.7% | -8.3% | +16.9% | +27.8% | -37.9% |
| EPS (₹) | 0.98 | 0.46 | (0.68) | (1.94) | 8.01 | 7.36 | (5.11) |
| Balance sheet | |||||||
| Total assets | - | 64.35 | 55.02 | 57.46 | 63.40 | 46.91 | 43.14 |
| Net worth | - | 50.91 | 48.80 | 48.32 | 50.58 | 36.25 | 24.93 |
| Total debt | - | 12.88 | 5.80 | 8.84 | 12.55 | 10.34 | 17.95 |
| Cash & bank | - | 0.21 | 0.51 | 6.12 | 29.71 | 5.68 | 1.88 |
| Net working capital | - | 23.64 | 19.34 | 21.65 | 39.91 | 14.09 | 6.93 |
| Cash flow | |||||||
| Cash from operations | - | 2.96 | 2.74 | (6.29) | 19.56 | 4.73 | (1.19) |
| Cash from investing | - | (9.84) | (4.69) | (7.27) | (1.20) | (0.80) | (1.02) |
| Cash from financing | - | 6.58 | (3.66) | (10.03) | 5.67 | (0.13) | 0.44 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 20.87 | 16.93 | 18.38 | 16.91 | 10.43 | 8.22 | 8.92 | 11.87 |
| Revenue growth (YoY) | +100.1% | +106.0% | +106.1% | +42.5% | +1.3% | -34.4% | - | - |
| Other income | 0.56 | 0.26 | 0.37 | 0.18 | 0.26 | 0.38 | 0.14 | 0.22 |
| Total expenses | 15.80 | 13.29 | 14.90 | 12.26 | 8.96 | 9.33 | 9.83 | 9.83 |
| EBITDA | 5.07 | 3.64 | 3.48 | 4.65 | 1.47 | (1.11) | (0.91) | 2.04 |
| EBITDA margin | +24.3% | +21.5% | +18.9% | +27.5% | +14.1% | -13.5% | -10.2% | +17.2% |
| Depreciation | 1.52 | 1.43 | 1.36 | 1.35 | 1.45 | 1.50 | 1.53 | 1.23 |
| Interest | 0.35 | 0.30 | 0.25 | 0.38 | 0.38 | 0.36 | 0.35 | 0.26 |
| Profit before tax | 3.76 | 2.17 | 2.24 | 3.10 | (0.10) | (2.59) | (2.65) | 0.77 |
| Tax | 1.01 | 0.30 | 0.64 | 0.80 | (0.01) | (0.43) | (1.31) | 0.44 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 23.17 | 18.28 | 21.29 | 19.07 | 12.38 | 8.80 | 10.06 | 12.51 |
| Revenue growth (YoY) | +87.2% | +107.7% | +111.6% | +52.4% | +8.6% | -31.7% | - | - |
| Other income | 0.44 | 0.17 | 0.29 | 0.14 | 0.20 | 0.33 | 0.15 | 0.23 |
| EBITDA | 5.71 | 2.95 | 4.29 | 5.23 | 2.07 | (1.78) | (0.38) | 2.08 |
| EBITDA margin | +24.6% | +16.1% | +20.2% | +27.4% | +16.7% | -20.2% | -3.8% | +16.6% |
| Depreciation | 1.80 | 1.70 | 1.61 | 1.60 | 1.69 | 1.74 | 1.77 | 1.48 |
| Interest | 0.48 | 0.44 | 0.41 | 0.54 | 0.55 | 0.54 | 0.55 | 0.43 |
| Profit before tax | 3.87 | 0.98 | 2.56 | 3.23 | 0.03 | (3.73) | (2.55) | 0.40 |
| Tax | 0.97 | 0.11 | 0.73 | 0.83 | 0.02 | (0.51) | (1.29) | 0.35 |
| Net profit | 2.90 | 0.87 | 1.83 | 2.40 | 0.01 | (3.22) | (1.26) | 0.05 |
| EPS (₹) | 1.44 | 0.43 | 1.09 | 1.52 | 0.01 | (2.03) | (0.79) | 0.03 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 61.54 | 46.84 | 39.65 | 36.18 | 67.79 | 46.95 | 23.94 |
| Revenue growth | +31.4% | +18.1% | +9.6% | -46.6% | +44.4% | +96.1% | - |
| Other income | 0.97 | 0.65 | 0.67 | 1.07 | 5.92 | 2.39 | 2.53 |
| Total expenses | 51.74 | 39.36 | 35.02 | 34.83 | 51.04 | 29.47 | 30.06 |
| Employee cost | 0.00 | 14.90 | 13.28 | 12.62 | 18.17 | 11.05 | 9.26 |
| EBITDA | 9.80 | 7.48 | 4.63 | 1.35 | 16.75 | 17.48 | (6.12) |
| EBITDA margin | +15.9% | +16.0% | +11.7% | +3.7% | +24.7% | +37.2% | -25.6% |
| Depreciation | 6.64 | 6.25 | 5.93 | 5.07 | 3.69 | 3.97 | 3.92 |
| Interest | 2.04 | 1.82 | 0.98 | 1.04 | 0.96 | 2.26 | 3.04 |
| Profit before tax | 2.09 | 0.06 | (1.61) | (3.69) | 18.02 | 13.64 | (10.55) |
| Tax | 1.06 | (0.01) | (0.28) | (0.61) | 6.09 | 1.91 | (1.96) |
| Net profit | 1.15 | 0.16 | (1.30) | (3.06) | 9.26 | 11.73 | (8.56) |
| Net profit margin | +1.9% | +0.3% | -3.3% | -8.5% | +13.7% | +25.0% | -35.8% |
| EPS (₹) | 0.61 | 0.08 | (0.84) | (1.97) | 7.81 | 7.67 | (5.61) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | - | 15.83 | 15.48 | 15.48 | 15.30 | 15.30 | 15.30 |
| Reserves & surplus | - | 34.11 | 32.95 | 32.71 | 35.28 | 19.72 | 7.92 |
| Shareholders' funds (net worth) | - | 49.94 | 48.43 | 48.19 | 50.58 | 35.02 | 23.22 |
| Minority interest | - | 0.13 | 0.20 | 0.23 | 0.00 | 0.00 | 0.00 |
| Secured loans | - | 14.30 | 9.71 | 5.15 | 4.23 | 10.29 | 10.58 |
| Unsecured loans | - | 6.28 | 3.70 | 4.95 | 8.32 | 0.05 | 7.37 |
| Total debt | - | 20.58 | 13.41 | 10.10 | 12.55 | 10.34 | 17.95 |
| Total liabilities | - | 71.21 | 62.45 | 58.83 | 63.40 | 45.69 | 41.43 |
| Assets | |||||||
| Gross block | - | 74.74 | 60.21 | 52.33 | 40.85 | 45.39 | 44.75 |
| Net block | - | 34.54 | 26.67 | 24.98 | 19.07 | 27.37 | 30.54 |
| Capital work in progress | - | 4.71 | 2.81 | 1.90 | 0.00 | 0.00 | 0.00 |
| Investments | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | - | 1.62 | 1.09 | 0.87 | 1.46 | 3.46 | 0.95 |
| Sundry debtors | - | 15.94 | 12.29 | 11.68 | 7.61 | 14.45 | 6.84 |
| Cash & bank balances | - | 0.24 | 0.54 | 6.83 | 29.71 | 6.21 | 2.20 |
| Loans & advances | - | 10.95 | 10.75 | 9.80 | 15.11 | 9.76 | 8.09 |
| Total current assets | - | 28.75 | 24.67 | 29.18 | 53.89 | 33.88 | 18.08 |
| Total current liabilities | - | 7.08 | 5.41 | 7.09 | 13.98 | 20.29 | 12.45 |
| Net working capital | - | 21.67 | 19.26 | 22.09 | 39.91 | 13.59 | 5.63 |
| Total assets | - | 71.21 | 62.45 | 58.83 | 63.40 | 45.69 | 41.43 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | - | 0.54 | 6.83 | 29.71 | 5.68 | 2.20 | 3.67 |
| Net cash from operating activities | - | 10.07 | 2.89 | (6.41) | 19.56 | 4.95 | (0.01) |
| Net cash from investing activities | - | (15.62) | (11.53) | (6.93) | (1.20) | (0.80) | (1.90) |
| Net cash from financing activities | - | 5.24 | 2.35 | (9.54) | 5.67 | (0.13) | 0.44 |
| Net change in cash | - | (0.30) | (6.29) | (22.88) | 24.03 | 4.02 | (1.47) |
| Closing cash | - | 0.24 | 0.54 | 6.83 | 29.71 | 6.21 | 2.20 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +31.4% | +18.1% | +9.6% | -46.6% | +44.4% | +96.1% | - |
| EBITDA growth | +31.0% | +61.6% | +243.0% | -91.9% | -4.2% | +385.6% | - |
| PBT growth | +3383.3% | +9998.0% | +56.4% | - | +32.1% | +9998.0% | - |
| Net income growth | +618.8% | +112.3% | +57.5% | -133.1% | -21.1% | +237.0% | - |
| Revenue CAGR (3Y) | +19.4% | -11.6% | -5.5% | +14.8% | +37.4% | +32.0% | +9.6% |
| EBITDA CAGR (3Y) | +93.6% | -23.6% | -35.8% | - | +42.0% | +72.1% | - |
| Profitability & leverage | |||||||
| Net income margin | +1.7% | +0.2% | -3.4% | -8.5% | +17.6% | +25.0% | -35.9% |
| Return on capital employed | - | +2.8% | -1.0% | -4.3% | +27.4% | +36.5% | 0.0% |
| Return on net worth | - | +0.1% | -2.8% | -6.2% | +21.7% | +40.3% | 0.0% |
| Debt / equity | - | 0.35 | 0.24 | 0.23 | 0.27 | 0.49 | 0.66 |
| Long-term debt / equity | - | 0.26 | 0.16 | 0.10 | 0.14 | 0.27 | 0.28 |
| Interest cover | 64.56 | 147.97 | -75.38 | -27.96 | 7.35 | 16.73 | -30.28 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 0.69 | 0.70 | 0.78 | 1.57 | 1.04 | 0.55 |
| Inventory turnover | - | 34.57 | 40.46 | 31.06 | 27.56 | 21.29 | 40.58 |
| Debtors turnover | - | 3.32 | 3.31 | 3.75 | 6.15 | 4.41 | 2.22 |
| EPS (₹) | 0.61 | 0.08 | (0.84) | (1.97) | 7.81 | 7.67 | (5.61) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 1.20 | 0.50 | 0.00 |
| Book value per share (₹) | 0.00 | 31.54 | 31.28 | 31.13 | 33.06 | 22.89 | 15.18 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 20.87 | 16.93 | 18.38 | 16.91 | 10.43 | 8.22 | 8.92 | 11.87 |
| Revenue growth (YoY) | +100.1% | +106.0% | +106.1% | +42.5% | +1.3% | -34.4% | - | - |
| Other income | 0.56 | 0.26 | 0.37 | 0.18 | 0.26 | 0.38 | 0.14 | 0.22 |
| Total expenses | 15.80 | 13.29 | 14.90 | 12.26 | 8.96 | 9.33 | 9.83 | 9.83 |
| EBITDA | 5.07 | 3.64 | 3.48 | 4.65 | 1.47 | (1.11) | (0.91) | 2.04 |
| EBITDA margin | +24.3% | +21.5% | +18.9% | +27.5% | +14.1% | -13.5% | -10.2% | +17.2% |
| Depreciation | 1.52 | 1.43 | 1.36 | 1.35 | 1.45 | 1.50 | 1.53 | 1.23 |
| Interest | 0.35 | 0.30 | 0.25 | 0.38 | 0.38 | 0.36 | 0.35 | 0.26 |
| Profit before tax | 3.76 | 2.17 | 2.24 | 3.10 | (0.10) | (2.59) | (2.65) | 0.77 |
| Tax | 1.01 | 0.30 | 0.64 | 0.80 | (0.01) | (0.43) | (1.31) | 0.44 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 53.93 | 43.61 | 38.50 | 36.18 | 56.55 | 40.47 | 20.57 |
| Revenue growth | +23.7% | +13.3% | +6.4% | -36.0% | +39.7% | +96.7% | - |
| Other income | 1.19 | 0.63 | 0.69 | 1.06 | 5.91 | 2.38 | 2.52 |
| Total expenses | 45.45 | 37.08 | 34.12 | 34.83 | 39.49 | 23.84 | 26.39 |
| Employee cost | 0.00 | 13.62 | 12.93 | 12.62 | 13.16 | 8.00 | 7.13 |
| EBITDA | 8.48 | 6.53 | 4.38 | 1.35 | 17.06 | 16.63 | (5.82) |
| EBITDA margin | +15.7% | +15.0% | +11.4% | +3.7% | +30.2% | +41.1% | -28.3% |
| Depreciation | 5.65 | 5.29 | 5.55 | 5.02 | 3.68 | 3.96 | 3.91 |
| Interest | 1.38 | 1.10 | 0.75 | 1.01 | 0.96 | 1.88 | 2.57 |
| Profit before tax | 2.64 | 0.77 | (1.23) | (3.62) | 18.33 | 13.17 | (9.78) |
| Tax | 0.99 | 0.03 | (0.18) | (0.61) | 6.09 | 1.92 | (1.96) |
| Net profit | 1.65 | 0.73 | (1.05) | (3.01) | 9.54 | 11.25 | (7.79) |
| Net profit margin | +3.1% | +1.7% | -2.7% | -8.3% | +16.9% | +27.8% | -37.9% |
| EPS (₹) | 0.98 | 0.46 | (0.68) | (1.94) | 8.01 | 7.36 | (5.11) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | - | 15.83 | 15.48 | 15.48 | 15.30 | 15.30 | 15.30 |
| Reserves & surplus | - | 35.08 | 33.32 | 32.84 | 35.28 | 20.95 | 9.63 |
| Shareholders' funds (net worth) | - | 50.91 | 48.80 | 48.32 | 50.58 | 36.25 | 24.93 |
| Secured loans | - | 7.68 | 3.43 | 4.85 | 4.23 | 10.29 | 10.58 |
| Unsecured loans | - | 5.20 | 2.37 | 3.99 | 8.32 | 0.05 | 7.37 |
| Total debt | - | 12.88 | 5.80 | 8.84 | 12.55 | 10.34 | 17.95 |
| Total liabilities | - | 64.35 | 55.02 | 57.46 | 63.40 | 46.91 | 43.14 |
| Assets | |||||||
| Gross block | - | 67.52 | 53.31 | 51.33 | 40.85 | 38.51 | 37.71 |
| Net block | - | 28.72 | 20.20 | 24.03 | 19.07 | 20.53 | 23.68 |
| Capital work in progress | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | - | 2.00 | 2.00 | 2.00 | 0.00 | 1.03 | 1.03 |
| Inventories | - | 0.93 | 1.01 | 0.87 | 1.46 | 4.94 | 0.95 |
| Sundry debtors | - | 14.39 | 11.93 | 11.68 | 7.61 | 12.46 | 6.00 |
| Cash & bank balances | - | 0.21 | 0.51 | 6.12 | 29.71 | 5.68 | 1.88 |
| Loans & advances | - | 14.38 | 10.78 | 9.27 | 15.11 | 7.87 | 7.85 |
| Total current assets | - | 29.91 | 24.23 | 27.94 | 53.89 | 30.95 | 16.68 |
| Total current liabilities | - | 6.27 | 4.89 | 6.29 | 13.98 | 16.86 | 9.75 |
| Net working capital | - | 23.64 | 19.34 | 21.65 | 39.91 | 14.09 | 6.93 |
| Total assets | - | 64.35 | 55.02 | 57.46 | 63.40 | 46.91 | 43.14 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | - | 0.51 | 6.12 | 29.71 | 5.68 | 1.88 | 3.66 |
| Net cash from operating activities | - | 2.96 | 2.74 | (6.29) | 19.56 | 4.73 | (1.19) |
| Net cash from investing activities | - | (9.84) | (4.69) | (7.27) | (1.20) | (0.80) | (1.02) |
| Net cash from financing activities | - | 6.58 | (3.66) | (10.03) | 5.67 | (0.13) | 0.44 |
| Net change in cash | - | (0.30) | (5.61) | (23.59) | 24.03 | 3.80 | (1.77) |
| Closing cash | - | 0.21 | 0.51 | 6.12 | 29.71 | 5.68 | 1.88 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +23.7% | +13.3% | +6.4% | -36.0% | +39.7% | +96.7% | - |
| EBITDA growth | +29.9% | +49.1% | +224.4% | -92.1% | +2.6% | +385.7% | - |
| PBT growth | +242.9% | +9998.0% | +66.0% | - | +39.2% | +9998.0% | - |
| Net income growth | +126.0% | +169.5% | +65.1% | -131.6% | -15.2% | +244.4% | - |
| Revenue CAGR (3Y) | +14.2% | -8.3% | -1.7% | +20.7% | +30.5% | +28.1% | +5.6% |
| EBITDA CAGR (3Y) | +84.5% | -27.4% | -35.9% | - | +43.1% | +71.1% | - |
| Profitability & leverage | |||||||
| Net income margin | +3.1% | +1.7% | -2.7% | -8.3% | +21.6% | +27.8% | -38.0% |
| Return on capital employed | - | +3.1% | -0.9% | -4.3% | +27.7% | +33.4% | 0.0% |
| Return on net worth | - | +1.5% | -2.2% | -6.1% | +22.0% | +36.8% | 0.0% |
| Debt / equity | - | 0.19 | 0.15 | 0.22 | 0.26 | 0.46 | 0.63 |
| Long-term debt / equity | - | 0.12 | 0.07 | 0.09 | 0.14 | 0.26 | 0.27 |
| Interest cover | 48.76 | 88.71 | -64.10 | -27.52 | 7.17 | 14.84 | -26.41 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 0.72 | 0.74 | 0.78 | 1.43 | 1.06 | 0.55 |
| Inventory turnover | - | 44.96 | 40.96 | 31.06 | 17.67 | 13.74 | 34.86 |
| Debtors turnover | - | 3.31 | 3.26 | 3.75 | 5.64 | 4.38 | 2.01 |
| EPS (₹) | 0.98 | 0.46 | (0.68) | (1.94) | 8.01 | 7.36 | (5.11) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 1.20 | 0.50 | 0.00 |
| Book value per share (₹) | 0.00 | 32.16 | 31.53 | 31.21 | 33.06 | 23.69 | 16.29 |
Web traffic of Jeevan Scientific Technology
The website of Jeevan Scientific Technology (jeevanscientific.com) receives about 1.8K visits a month.
- Monthly visits1.8K
▲ 50% vs previous month
Top companies in Business Process Outsourcing (BPO)
3 companies that operate in the same segment as Jeevan Scientific Technology (Business Process Outsourcing (BPO)) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of outsourcing and business services | 2007 | Bengaluru, Karnataka, India | USD 1.63 B | 299 | ||
Cloud-based text analytics and cognitive automation services are provided. | 1975 | Mumbai, Maharashtra, India | USD 3 M | USD 217.77 M | 5,560 | |
Electricity generation and distribution are provided in eastern India. | 1879 | Kolkata, West Bengal, India | USD 2.03 B | 5,688 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Jeevan Scientific Technology
Complete news archive for Jeevan Scientific Technology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jeevan Scientific Technology
Jeevan Scientific Technology was founded in 1999.
Jeevan Scientific Technology is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Rajendra Prasad Muppavarapu is the CEO of Jeevan Scientific Technology, as recorded in our data.
Jeevan Scientific Technology has 263 employees.
The primary company behind Jeevan Scientific Technology, Jeevan Scientific Technology Limited, reported revenue of ₹62.51 Cr for FY 2026, up 31% year on year.
Jeevan Scientific Technology was founded in 1999 and is headquartered in Hyderabad, India. Outsourcing services in the healthcare sector are delivered, including support for clinical and operational needs. The company operates from its Indian base, serving clients in pharmaceuticals and related fields. Leadership is held by CEO Rajendra Prasad Muppavarapu, with a focus on established processes in the domain.
Jeevan Scientific Technology offers BA/BE Studies, Clinical Trial Services, and Pharmacovigilance Services.
Yes, Jeevan Scientific Technology is publicly traded on BSE under the ticker symbol JSTL.
Jeevan Scientific Technology is associated with 2 legal entities: Jeevan Scientific Technology Limited, Jstl Pharma Llp.
The legal entities of Jeevan Scientific Technology currently have 12 directors, including Krishna Kishore Kuchipudi, Kuchipudi Vanaja, Jeevan Krishna Kuchipudi and others.
